Tekla Life Sciences Investors (HQL) Financials

HQL Assets vs Liabilities
DateAssetsLiabilities
Sept. 30, 2024 460.6 million 888610
March 31, 2024 441.9 million 879912
Dec. 31, 2023 441.9 million 879912
Sept. 30, 2023 402.6 million 666959

HQL Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2024 ? ?
March 31, 2024 ? ?
Dec. 31, 2023 ? ?
Sept. 30, 2023 ? ?

HQL Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
Sept. 30, 2024 ?
March 31, 2024 ?
Dec. 31, 2023 ?
Sept. 30, 2023 11.2 million

HQL Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2024 1 - -
March 31, 2024 13.8 million - -
Dec. 31, 2023 - - -
Sept. 30, 2023 477 - -

HQL Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2024 28.8 million
March 31, 2024 27.4 million
Dec. 31, 2023 27.4 million
Sept. 30, 2023 26.8 million

HQL Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2024 - - 3.2 million 16492
March 31, 2024 - - 2.7 million 8114
Dec. 31, 2023 - - 2.7 million 8114
Sept. 30, 2023 - - - -

HQL Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2024 1.9 million -
March 31, 2024 2.1 million 2.5 million
Dec. 31, 2023 2.1 million -
Sept. 30, 2023 29.6 million 2.6 million

HQL

Price: $16.51

52 week price:
12.34
18.46

Dividend Yield: 11.81%

5-year range yield:
8.93%
14.18%

Forward Dividend Yield: 13.35%

Payout Ratio: 146.27%

Dividend Per Share: 2.24 USD

Earnings Per Share: 2.79 USD

P/E Ratio: 5.77

Exchange: NYQ

Sector: Financial Services

Industry: Asset Management

Country: United States

Volume: 93486

Market Capitalization: 525.1 million

Average Dividend Frequency: 4

Years Paying Dividends: 31

DGR3: 8.01%

DGR5: 7.16%

DGR10: 0.66%

DGR20: 22.46%

Links: